Xeroderma pigmentosum family support group: Helping families and promoting clinical initiatives

DNA Repair

Volumn 10, Issue 7, 2011, Pages 792-797

  Milota, Michele ^a   Jones, Debby Livingstone ^a   Cleaver, James ^a,b   Jamall, Ijaz S ^a  

^a XP Family Support Group   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Skin cancer; Sunlight; Xeroderma pigmentosum; XP Family Support Group

Indexed keywords

CALCIUM; ISOTRETINOIN; PEPTIDES AND PROTEINS; PROTEIN XPE; PROTEIN XPV; REACTIVE OXYGEN METABOLITE; RETINOL PALMITATE; SELENIUM; SUNSCREEN; UNCLASSIFIED DRUG; VITAMIN D; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ACTINIC KERATOSIS; APOPTOSIS; BREAST CANCER; CANADA; DISEASE SEVERITY; DNA DAMAGE; DNA REPAIR; DOSIMETER; EUROPE; FAMILY ATTITUDE; FUNDING; GENE; GUATEMALA; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFECTION; LEUKEMIA; LOSS OF FUNCTION MUTATION; MELANOMA; MUSCULAR DYSTROPHY; NEOPLASM; NERVE DEGENERATION; NEUROLOGIC DISEASE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTECTIVE CLOTHING; PROTECTIVE EQUIPMENT; PROTEIN METHYLATION; RADIATION DOSE; RARE DISEASE; REVIEW; RISK ASSESSMENT; SKIN CANCER; SKIN PIGMENTATION; SOCIAL INTERACTION; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SUPPORT GROUP; ULTRAVIOLET RADIATION; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; XERODERMA PIGMENTOSUM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE, INTEGRATED; FAMILY; FEMALE; HUMANS; MALE; MIDDLE AGED; RARE DISEASES; SELENIUM; SELF-HELP GROUPS; SUNSCREENING AGENTS; ULTRAVIOLET RAYS; VITAMIN A; VITAMIN D; XERODERMA PIGMENTOSUM; YOUNG ADULT;

EID: 79960352669     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2011.04.027     Document Type: Review

References (36)

1. Cleaver J.E., Feeney L., Tang J.Y., Tuttle P. Xeroderma pigmentosum group C in an isolated region of Guatemala. J. Invest. Dermatol. 2007, 127:493-496.
2. de Feraudy S., Boubakour-Azzouz I., Fraitag S., Berneburg M., Chan L., Chew K., Clericuzio C.L., Cunningham B., Tope W.D., Cleaver J.E. Diagnosing xeroderma pigmentosum group C by immunohistochemistry. Am. J. Dermatopathol. 2010, 32:109-117.
3. Nishigori C., Zghal M., Yagi T., Imamura S., Komoun M.R., Takebe H. High prevalence of point mutations in exon 6 of xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia. Am. J. Hum. Genetics 1993, 53:1001-1006.
4. Satokata I., Tanaka K., Yuba S., Okada Y. Identification of splicing mutations of the last nucleotide of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum. Mutat. Res. 1992, 273:203-212.
5. Gozukara E.M., Khan S.G., Metin A., Emmert S., Busch D.B., Shahlavi T., Coleman D.M., Miller M., Chinsomboon N., Stefanini M., Kraemer K.H. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor. J. Invest. Dermatol. 2001, 117:197-204.
6. Diffey B.L. Stratospheric ozone depletion and the risk of non-melanoma skin cancer in a British population. Phys. Med. Biol. 1992, 37:2267-2279.
7. de Gruijl F.R., Sterenborg H.J.C.M., Forbes P.D., Davies R.E., Cole C., Keffkens G., van Weelden H., Slaper H., van der Leun J.C. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res. 1993, 53:53-60.
8. Vishvakarman D., Wong J.C.F. Description of the use of a risk assessment model to assess the increased risk of non-melanoma skin cancer among outdoor workers in Central Queensland, Australia. Photodermatol. Photoimmunol. Photomed. 2003, 19:81-88.
9. Goder D.E. UV doses of American children and adolescents. Photochem. Photobiol. 2001, 74:787-793.
10. Goder D.E., Urbach F., Gasparro F.P., van der Leun J.C. UV doses of young adults. Photochem. Photobiol. 2003, 77:453-457.
11. McKenzie R.L., Bjorn L.O., Bais A., Ilyas M. Changes in biologically active ultraviolet radiation reaching the earth's surface. Photochem. Photobiol. Sci. 2003, 2:5-15.
12. Rogers H., Weinstock M.A., Harris A.R., Hinckley M.R., Feldman S.R., Fleisher A.B., Caldiron B.M. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch. Dermatol. 2010, 146:283-287.
13. Thieden E., Philipse P.A., Sandby-Meller J., Heydenreich J., Wulf H.C. Proportion of lifetime UV dose received by children, teenagers and adults based on time-stamped personal dosimetry. J. Invest. Dermatol. 2004, 123:1147-1150.
14. Heydenreich J., Wulf H.C. Miniature personal electronic UVR dosimeter with erythema response and time-stamped readings in a wristwatch. Photochem. Photobiol. 2005, 81:1136-1144.
15. Garcia M., Llames S., Garcia E., Meana A., Cuadrado N., Recasens M., Puig S., Nagore E., Illera N., Jorcano J.L., Rio M.D., Larcher F. In vivo assessment of Acute UVB responses in normal and Xeroderma pigmentosum (XP-C) skin-Humanized mouse models. Am. J. Pathol. 2010, 177:865-872.
16. Australian Radiation Protection and Nuclear Safety Agency, Occupational exposure to ultraviolet radiation, Radiation Protection Series No. 12, December 2006.
17. Mei N., Xia Q., Chen L., Moore M.M., Fu P.P., Chen T. Photomutagenicity of retinyl palmitate by ultraviolet A irradiation in mouse lymphoma cells. Toxicol. Sci. 2005, 88:142-149.
18. Mei N., Xia Q., Chen L., Moore M.M., Chen T., Fu P.P. Photomutagenicity of anhydroretinol and 5, 6-epoxyretinyl palmitate in mouse lymphoma cells. Chem. Res. Toxicol. 2006, 19:1435-1440.
19. Yin J.J., Xia Q., Fu P.P. UVA photoirradiation of anhydroretinol-formation of singlet oxygen and superoxide. Toxicol. Ind. Health 2007, 23:625-631.
20. Fu P.P., Xia Q., Yin J.J., Cherng S.H., Yan J., Mei N., Chen T., Bodreau M.D., Howard P.C., Warner W.G. Photodecomposition of vitamin A and photobiological implications for the skin. Photochem. Photobiol. 2007, 83:409-424.
21. Mei N., Chen T., Godar D.E., Moore M.M. UVA-induced photomutagenicity of retinyl palmitate. Mutat. Res. 2009, 677:105-106.
22. Gallagher R.P., Lee T.K. Adverse effects of ultraviolet radiation: a brief review. Prog. Biophys. Mol. Biol. 2006, 92:119-131.
23. Cleaver J.E., Revet I. Clinical implications of the basic defects in Cockayne syndrome and xeroderma pigmentosum and the DNA lesions responsible for cancer, neurodegeneration and aging. Mech. Ageing Dev. 2008, 129:492-497.
24. Frechet M., Warrick E., Vioux C., Chevallier O., Spatz A., Benhamou S., Sarasain A., Bernerd F., Magnaldo R. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients. Oncogene 2008, 27:5223-5232.
25. Wang S.Q., Dusza S.W., Lim H.W. Safety of retinyl palmitate in sunscreens: a critical analysis. J. Am. Acad. Dermatol. 2010, 63:903-906.
26. Kraemer K.H., Giovanna J.J., Moshell A.N., Tarone R.E., Peck G.L. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N. Engl. J. Med. 1988, 318:1633-1637.
27. Lappe M.J., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 2007, 85:1586-1591.
28. Peterlik M., Grant W.B., Cross H.S. Calcium, vitamin D and cancer. Anticancer Res. 2009, 29:3687-3698.
29. Pilz S., Tomaschitz A., Obermayer-Pietch B., Dobnig H., Pieber T.R. Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res. 2009, 29:3699-3704.
30. Mansbach J.M., Ginde A.A., Camargo C.A. Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D?. Pediatrics 2009, 124:1404-1410.
31. Madhunapantula S.V., Desai D., Sharma A., Huh S.J., Amin S., Robertson G.P. PBISe, a novel selenium-containing drug for the treatment of malignant melanoma. Mol. Cancer Ther. 2008, 7:1297-1308.
32. Chen T., Wong Y.S. Selenocystine induces reactive oxygen species-mediated apoptosis in human cancer cells. Biomed. Pharmacother. 2008, 63:105-113.
33. Traynor N.J., McKenzie R.C., Beckett G.J., Gibbs N.K. Selenomethionine inhibits ultraviolet radiation-induced p53 transactivation. Photodermatol. Photoimmunol. Photomed. 2006, 22:297-303.
34. Burke K.E., Clive J., Combs G.F., Nakamura R.M. Effects of topical l-selenomethionine with topical and oral vitamin E on pigmentation and skin cancer induced by ultraviolet irradiation in Skh:2 hairless mice. J. Am. Acad. Dermatol. 2003, 49:458-472.
35. McKenzie R.C., Beckett G.J. Mechanisms of selenium-mediated protection from photocarcinogenesis and cell death are not solely p53-dependent. J. Photochem. Photobiol. 2003, 71:99-101.
36. Jamall I.S., Ally K.M., Yusuf S. Acrodermatitis enteropathica: zinc therapy and possible identification of a carrier state through multiple hair zinc analyses over three decades. Biol. Trace Elem. Res. 2006, 114:93-105.